Skip to content

Greater Trochanter Epiphysiodesis In Hip Pathology

Outcomes of The Greater Trochanter Epiphysiodesis In Treatment Of Children With Hip Pathology

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05194774
Enrollment
20
Registered
2022-01-18
Start date
2022-01-31
Completion date
2024-01-31
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedic Disorder

Brief summary

One of the most common problems in the treatment of pediatric patients with various disorders of the hip joint is the formation of deformity of the proximal femur, such as abnormal growth of the greater trochanter, which causes it to be positioned high in relation to the femoral head. This condition is called relative overgrowth of the greater trochanter (ROGT).

Interventions

PROCEDUREGreater Trochanter epiphysiodesis

epiphysiodesis by cortical screw and washer

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 10 Years

Inclusion criteria

* emerging deformities of the proximal femur with a high position of the greater trochanter, in which its apex was located above the center of the femoral head but below its superior pole; changes in the structure of the femoral neck, accompanied by its shortening; functioning growth zone of the greater trochanter at the time of intervention; and patients without surgical treatment history

Exclusion criteria

* hip dislocation upon examination; patients with varus deformity of the femoral neck (neck-shaft angle \<120°), patients with complications of surgical interventions, trauma, rickets, and rheumatoid arthritis; and patients with neurological disorders and Refusal to participate in this study

Design outcomes

Primary

MeasureTime frameDescription
Radiological measurments12 montharticulo-trochanteric distance

Contacts

Primary ContactMuhammed Yasser, MD
docmuhammed1@gmail.com0201061303076
Backup ContactAmer Alkott, MD
amerabomosab@yahoo.com01002329851

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026